Pfizer/BioNTech Says Its COVID-19 Vaccine Is 100% Effective And Well Tolerated In Adolescents
Clinical trial results of Pfizer/BioNTech's COVID-19 vaccine showed its efficacy is 100% and it is well tolerated in youths ages 12 to 15, the companies said Wednesday.